Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "No direct cellular target" is applied to therapeutic agents that do not achieve their clinical effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or transporter. Instead, these agents operate through fundamental physical or chemical mechanisms. Common examples include antacids that neutralize hydrochloric acid in the stomach via simple acid-base chemistry and osmotic laxatives like polyethylene glycol that increase bowel water content through osmotic pressure (StatPearls, NBK526049; NBK537246). Additionally, this category encompasses chelating agents used to treat heavy metal poisoning by sequestering ions and adsorbents like activated charcoal that physically trap toxins within the gastrointestinal tract (NCBI, PMC3654245). Because these substances do not rely on specific protein-ligand interactions, they are generally not subject to traditional receptor-mediated resistance. However, their use can significantly alter physiological parameters, leading to challenges such as electrolyte disturbances or the impaired absorption of other medications. This classification is essential for distinguishing non-specific chemical interventions from targeted molecular therapies in pharmacological research.
Drugs in this category function through direct chemical reactions, such as the neutralization of gastric acid by basic salts (StatPearls, NBK526049), or through physical processes like the creation of an osmotic gradient to retain water in the intestinal lumen (StatPearls, NBK537246). They may also act by sequestering specific molecules or ions through chelation or adsorption (NCBI, PMC3654245).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No direct cellular target.